Ochratoxin A: Molecular Interactions, Mechanisms of Toxicity and Prevention at the Molecular Level

Overview

Journal Toxins (Basel)

Publisher MDPI

Specialty Toxicology

Date 2016 Apr 20

PMID 27092524

Citations 85

Authors

Tamas Koszegi

Miklos Poor

Affiliations

Soon will be listed here.

Abstract

Ochratoxin A (OTA) is a widely-spread mycotoxin all over the world causing major health risks. The focus of the present review is on the molecular and cellular interactions of OTA. In order to get better insight into the mechanism of its toxicity and on the several attempts made for prevention or attenuation of its toxic action, a detailed description is given on chemistry and toxicokinetics of this mycotoxin. The mode of action of OTA is not clearly understood yet, and seems to be very complex. Inhibition of protein synthesis and energy production, induction of oxidative stress, DNA adduct formation, as well as apoptosis/necrosis and cell cycle arrest are possibly involved in its toxic action. Since OTA binds very strongly to human and animal albumin, a major emphasis is done regarding OTA-albumin interaction. Displacement of OTA from albumin by drugs and by natural flavonoids are discussed in detail, hypothesizing their potentially beneficial effect in order to prevent or attenuate the OTA-induced toxic consequences.

Citing Articles

Potential role of ochratoxin A in Parkinson's disease: a systematic review of current evidence.

Serrano-Civantos M, Beraza E, Alvarez-Erviti L, de Cerain A, Vettorazzi A Arch Toxicol. 2025; .

PMID: 40044834 DOI: 10.1007/s00204-025-03994-5.

Effect of Major Mycotoxins on Public Health Through the Consumption of Cheese Products.

Chaidoutis E, Chatzimpirou O, Migdanis I, Migdanis A, Papadakis A, Lazaris A Malays J Med Sci. 2025; 31(6):21-33.

PMID: 39830105 PMC: 11740815. DOI: 10.21315/mjms2024.31.6.3.

The Role of AFB1, OTA, TCNs, and Patulin in Forensic Sciences: Applications in Autopsy, Criminal Investigations, and Public Health Prevention.

Sacco M, Gualtieri S, Tarallo A, Verrina M, Carbone A, Mazzuca W Toxins (Basel). 2024; 16(12.

PMID: 39728772 PMC: 11728568. DOI: 10.3390/toxins16120514.

Ochratoxin A in food commodities: A review of occurrence, toxicity, and management strategies.

Banahene J, Ofosu I, Odai B, Lutterodt H, Agyemang P, Ellis W Heliyon. 2024; 10(20):e39313.

PMID: 39640601 PMC: 11620267. DOI: 10.1016/j.heliyon.2024.e39313.

Alterations in the proteomes of HepG2 and IHKE cells inflicted by six selected mycotoxins.

Keuter L, Fortmann M, Behrens M, Humpf H Arch Toxicol. 2024; 99(2):701-715.

PMID: 39638853 PMC: 11775057. DOI: 10.1007/s00204-024-03905-0.

References

Gannett P, Powell J, Rao R, Shi X, Lawson T, Kolar C . C8-Arylguanine and C8-aryladenine formation in calf thymus DNA from arenediazonium ions. Chem Res Toxicol. 1999; 12(3):297-304. DOI: 10.1021/tx980179f. View

Kusuhara H, Sekine T, Tsuda M, Kojima R, Cha S, Sugiyama Y . Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J Biol Chem. 1999; 274(19):13675-80. DOI: 10.1074/jbc.274.19.13675. View

Hohler D, Sudekum K, Wolffram S, Frohlich A, Marquardt R . Metabolism and excretion of ochratoxin A fed to sheep. J Anim Sci. 1999; 77(5):1217-23. DOI: 10.2527/1999.7751217x. View

McMasters D, Vedani A . Ochratoxin binding to phenylalanyl-tRNA synthetase: computational approach to the mechanism of ochratoxicosis and its antagonism. J Med Chem. 1999; 42(16):3075-86. DOI: 10.1021/jm991040k. View

Schwerdt G, Freudinger R, Silbernagl S, Gekle M . Ochratoxin A-binding proteins in rat organs and plasma and in different cell lines of the kidney. Toxicology. 1999; 135(1):1-10. DOI: 10.1016/s0300-483x(99)00028-1. View

Dopp E, Muller J, Hahnel C, Schiffmann D . Induction of genotoxic effects and modulation of the intracellular calcium level in syrian hamster embryo (SHE) fibroblasts caused by ochratoxin A. Food Chem Toxicol. 1999; 37(7):713-21. DOI: 10.1016/s0278-6915(99)00057-5. View

BLANC , Pittet , Viani . Behavior of Ochratoxin A during Green Coffee Roasting and Soluble Coffee Manufacture. J Agric Food Chem. 2001; 46(2):673-675. DOI: 10.1021/jf9707703. View

Gillman I, Clark T, Manderville R . Oxidation of ochratoxin A by an Fe-porphyrin system: model for enzymatic activation and DNA cleavage. Chem Res Toxicol. 1999; 12(11):1066-76. DOI: 10.1021/tx9901074. View

Peraica M, Domijan A, Fuchs R, Lucic A, Radic B . The occurrence of ochratoxin A in blood in general population of Croatia. Toxicol Lett. 1999; 110(1-2):105-12. DOI: 10.1016/s0378-4274(99)00141-1. View

10.

Kerkadi A, Barriault C, Marquardt R, Frohlich A, Yousef I, Zhu X . Cholestyramine protection against ochratoxin A toxicity: role of ochratoxin A sorption by the resin and bile acid enterohepatic circulation. J Food Prot. 1999; 62(12):1461-5. DOI: 10.4315/0362-028x-62.12.1461. View

11.

Benesic A, Mildenberger S, Gekle M . Nephritogenic ochratoxin A interferes with hormonal signalling in immortalized human kidney epithelial cells. Pflugers Arch. 2000; 439(3):278-87. DOI: 10.1007/s004249900172. View

12.

Cha S, Sekine T, Kusuhara H, Yu E, Kim J, Kim D . Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J Biol Chem. 2000; 275(6):4507-12. DOI: 10.1074/jbc.275.6.4507. View

13.

El Adlouni C, Pinelli E, Azemar B, Zaoui D, Beaune P, Pfohl-Leszkowicz A . Phenobarbital increases DNA adduct and metabolites formed by ochratoxin A: role of CYP 2C9 and microsomal glutathione-S-transferase. Environ Mol Mutagen. 2000; 35(2):123-31. DOI: 10.1002/(sici)1098-2280(2000)35:2<123::aid-em7>3.3.co;2-c. View

14.

Leier I, Cui Y, Keppler D . ATP-dependent para-aminohippurate transport by apical multidrug resistance protein MRP2. Kidney Int. 2000; 57(4):1636-42. DOI: 10.1046/j.1523-1755.2000.00007.x. View

15.

Gekle M, Schwerdt G, Freudinger R, Mildenberger S, Wilflingseder D, Pollack V . Ochratoxin A induces JNK activation and apoptosis in MDCK-C7 cells at nanomolar concentrations. J Pharmacol Exp Ther. 2000; 293(3):837-44. View

16.

Vrabcheva T, Usleber E, Dietrich R, Martlbauer E . Co-occurrence of ochratoxin A and citrinin in cereals from Bulgarian villages with a history of Balkan endemic nephropathy. J Agric Food Chem. 2000; 48(6):2483-8. DOI: 10.1021/jf990891y. View

17.

Schlatter J, Dietrich D . Kinetic parameters and intraindividual fluctuations of ochratoxin A plasma levels in humans. Arch Toxicol. 2000; 74(9):499-510. DOI: 10.1007/s002040000157. View

18.

Zepnik H, Pahler A, Schauer U, Dekant W . Ochratoxin A-induced tumor formation: is there a role of reactive ochratoxin A metabolites?. Toxicol Sci. 2001; 59(1):59-67. DOI: 10.1093/toxsci/59.1.59. View

19.

Atroshi F, Biese I, Saloniemi H, Ali-Vehmas T, Saari S, Rizzo A . Significance of apoptosis and its relationship to antioxidants after ochratoxin A administration in mice. J Pharm Pharm Sci. 2001; 3(3):281-91. View

20.

Ozcelik N, Kosar A, Soysal D . Ochratoxin A in human serum samples collected in Isparta-Turkey from healthy individuals and individuals suffering from different urinary disorders. Toxicol Lett. 2001; 121(1):9-13. DOI: 10.1016/s0378-4274(00)00291-5. View